CDKN2A and neoplasm: However, the availability of this RNA methodology and concern for lower sensitivity compared to the affordable HPV-DNA polymerase chain reaction (PCR) led to the evaluation of IHC-p16 protein as a surrogate marker for the presence of active HPV in tumor cells [15].